Previous Close | 138.38 |
Open | 139.09 |
Bid | 0.00 x 800 |
Ask | 0.00 x 1100 |
Day's Range | 138.43 - 140.27 |
52 Week Range | 99.54 - 143.09 |
Volume | 1,108,436 |
Avg. Volume | 5,523,970 |
Market Cap | 34.908B |
Beta (5Y Monthly) | 0.98 |
PE Ratio (TTM) | 43.70 |
EPS (TTM) | 3.21 |
Earnings Date | May 10, 2021 - May 14, 2021 |
Forward Dividend & Yield | 3.08 (2.20%) |
Ex-Dividend Date | Mar 25, 2021 |
1y Target Est | 148.94 |
IFF today announced the launch of Enovera™ 3001, an enzyme-only solution as the newest addition to IFF's range of ingredients for the bakery industry. This exciting new enzyme is from the Danisco® range of ingredients that became part of the IFF family earlier this year. Enovera™ 3001 is a next-generation enzyme-only dough strengthener available to bakery manufacturers interested in label-friendly formulations without trade-offs. It allows industrial bakers to formulate without compromising dough strength, texture or taste.
International Flavors (IFF) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
As part of the deal, IFF said Sachem Head had agreed, at least temporarily, not to take on an activist role in terms of influencing shareholders. Ferguson, managing partner at Sachem Head, will have the option to join IFF's board between Sept. 10 and Dec. 31, the company said.